Tirzepatide (Mounjaro, Zepbound) Tirzepatide targets both GLP-1 and GIP receptors, producing greater average weight loss than semaglutide in head-to-head trials, typically 20 to 25 percent of body weight
Well-hydrated skin cells turn over more efficiently, accelerating the fading of dark spots and preventing the formation of new pigmentation irregularities
With continued use, skin appears more resilient and lifted, while the look of fine lines, wrinkles and uneven texture is visibly diminished
Common initial side effects include mild nausea, reduced appetite, and occasional constipationmost of which improve within 24 weeks as your body adapts
Research recently conducted at the George Washington University Medical Center indicates that in addition to promoting the Krebs cycle, l-carnitine fumarate helps moderate lactate levels in the hearts of laboratory animals